Can a virtual ED reduce diabetes hospitalisations? A new initiative is hoped to ease ED loads and improve access to treatment, but there are concerns it may also fragment general practice care.
‘Enough talking’: Government called upon to help GPs treat diabetes Health leaders must act upon recent expert advice pleading for urgent improvement to patients’ access to quality diabetes care, says the RACGP.
Sweeping change needed amid ‘diabetes epidemic’: Inquiry The RACGP says prevention is key, as Medicare reform, bolstered rural access, sugar taxes, and CGM subsidies were all recommended.
PBS restrictions placed on diabetes medicines GPs now need to gain additional approval prior to starting patients on all GLP-1 RAs, including semaglutide.
Study links Ozempic to kidney failure prevention It found semaglutide reduced risk of major kidney events by 24% for type 2 diabetes patients, but GPs have urged caution.
Replica Ozempic and Mounjaro to be banned The Government has removed a loophole allowing the mass production of the compounded drugs amid growing patient safety concerns.
Warning issued on point-of-care testing compliance Despite thousands of MBS claims, the DoHAC understands no clinics are approved for the HbA1c test, sparking calls for practices to get accredited.
Sydney home raided after Ozempic scam The TGA is urging GPs ‘exercise deep caution’ after doctors were faxed ads promoting allegedly illegally compounded semaglutide.
How RACGP Foundation seed funding blossomed into MRFF grant What started as a small, GP-led diabetes research project recently received close to $1 million to expand into other areas of chronic disease.
In Practice: Updates to allied health MBS items Referral changes to MBS items for Aboriginal and Torres Strait Islander patients accessing allied health services are now in place.